3Adjuik, M., Babiker, A., Garner, P., Olliaro, P., Taylor, W., White, N., 2004. Artesunate combinations for treatment of malaria: meta-analysis. Lancet, 363(9402):9-17. [doi: 10.1016/S0140-6736(03)15162-8].
4Altieri, D.C., 2003. Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene, 22(53): 8581-8589. [doi:10.1038/sj.onc.1207113].
5Berger, T.G., Dieckmann, D., Efferth, T., Schultz, E.S., Funk, J.O., Baur, A., Schuler, G., 2005. Artesunate in the treatment of metastatic uveal melanoma--first experiences. Oncol Reports, 14(6): 1599-1603.
6Bossy-Wetzel, E., Green, D.R., 1999. Caspases induce cytochrome c release from mitochondria by activating cytosolic factors. J. Biol. Chem., 274(25):17484-17490. [doi: 10.1074/jbc.274.25.17484].
7Brama, M., Rhodes, N., Hunt, J., Ricci, A., Teghil, R., Migliaccio, S., Rocca, C.D., Leccisotti, S., Lioi, A., Scandurra, M., et al., 2007. Effect of titanium carbide coating on the osseointegration response in vitro and in vivo. Biomaterials, 28(4):595-608. [doi:10.1016/j.biomaterials.2006.08.018].
8Chou, A.J., Gorlick, R., 2006. Chemotherapy resistance in osteosarcoma: current challenges and future directions. Expert Rev. Anticancer Ther., 6(7):1075-1785. [doi:10. 1586/14737140.6.7.1075].
9Dell'Eva, R., Pfeffer, U., Vene, R., Anfosso, L., Forlani, A., Albini, A., Efferth, T., 2004. Inhibition of angiogenesis in vivo and growth of Kaposi's sarcoma xenograft tumors by the anti-malarial artesunate. Biochem. Pharmaeol., 68(12):2359-2366. [doi:10.1016/j.bcp.2004.08.021].
10Doherty, J.F., Sadiq, A.D., Bayo, L., Alloueche, A., Olliaro, P., Milligan, P., von Seidlein, L., Pinder, M., 1999. A randomized safety and tolerability trial of artesunate plus sulfadoxine--pyrimethamine versus sulfadoxine- pyrimethamine alone for the treatment of uncomplicated malaria in Gambian children. Trans. R. Soc. Trop. Med. Hyg., 93(5):543-546. [doi: 10.1016/S0035-9203(99)90376-0].
